Silvana Novelli's Avatar

Silvana Novelli

@snovelli.bsky.social

Hematologist. #Lymphoma #immunotherapy #ITP 🏥 Institut Català d’Oncologia- Barcelona. Tap dancer 🎼

220 Followers  |  299 Following  |  57 Posts  |  Joined: 14.11.2024
Posts Following

Posts by Silvana Novelli (@snovelli.bsky.social)

Post image

The $100 whole human genome sequence finally reached!
www.sandiegouniontribune.com/2026/02/19/s...

20.02.2026 20:29 — 👍 258    🔁 77    💬 12    📌 11
Post image

Read the first #PreprintWatch of 2026 which delves into healthy hematopoiesis, from the most immature stem cells to more committed progenitors. This issue also features community submissions from Constanze Bonifer, @boierslab.bsky.social and more➡️ iseh.org/Publications...

27.01.2026 21:00 — 👍 2    🔁 1    💬 0    📌 0
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies The treatment landscape of classical Hodgkin lymphoma continues to evolve with earlier use of novel agents. Most recently, the addition of PD-1 inhibitors into frontline therapy has improved cure rate...

Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies - Hematology/Oncology Clinics www.hemonc.theclinics.com/article/S088...

07.01.2026 20:58 — 👍 0    🔁 0    💬 0    📌 0
Preview
CAP Aims to Improve Early Diagnosis of Amyloidosis With New Guideline The College of American Pathologists published a guideline for the laboratory workup of amyloidosis.

The @pathologists.bsky.social published a guideline for the laboratory workup of #amyloidosis in the Archives of Pathology & Laboratory Medicine.

https://bit.ly/496t2I9

05.01.2026 18:13 — 👍 1    🔁 1    💬 0    📌 0
Preview
Microbiota utilization of intestinal amino acids modulates cancer progression and anticancer immunity Qiao et al. identify gut microbes and amino acid-metabolizing genes that influence tumor burden. A Bacteroides asparaginase, bo-ansB, modulates host tumor responses to dietary asparagine (Asn) by depl...

Microbiota utilization of intestinal amino acids modulates cancer

Bacteroides asparaginase, bo-ansB, modulates host tumor responses to dietary asparagine by depleting Asn w/in TME. Reduced Asn impacts stemness of intratumoral CD8 T cells & tumor burden
www.cell.com/cell-host-mi...

06.01.2026 16:47 — 👍 3    🔁 1    💬 0    📌 0
Post image

CD8+ T-cell activation, function, and metabolic reprogramming are suppressed by hypoxia, linked to decreased mTOR activity. Read in Blood Advances: buff.ly/ttZb0at #BloodAdvances #MultipleMyeloma

17.12.2025 16:30 — 👍 1    🔁 1    💬 0    📌 0
Preview
Method of the Year: EM connectomics - Nature Methods Using electron microscopy, scientists mapped a Caenorhabditis elegans nervous system and Drosophila brain at single-neuron resolution. Connectomics work on bigger brains takes new methods strategies.

Method of the Year 2025: In her feature, @vivienm.bsky.social asks scientists about their strategies and decision-making as they scale EM-based approaches for larger brains.

www.nature.com/articles/s41...

08.12.2025 22:25 — 👍 17    🔁 7    💬 0    📌 0
Cell-of-Origin Subtype Predicts Response to Polatuzumab Vedotin in Large B-cell Lymphoma AbstractPurpose:. Polatuzumab vedotin (polatuzumab) was approved for up-front treatment of diffuse large B-cell lymphoma in combination with chemoimmunotherapy (Pola-R-CHP) based on the POLARIX trial....

Hans IHC discrimination of Cell-of-Origin Subtype is a valid method for predicting Polatuzumab response in DLBCL aacrjournals.org/clincancerre...

30.11.2025 16:32 — 👍 1    🔁 1    💬 0    📌 0
Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy AbstractPurpose:. Chimeric antigen receptor T cells (CAR-T) have demonstrated remarkable efficacy in multiple myeloma, but prolonged hematologic toxicity remains a common adverse event, and secondary ...

Should we start seeking clonal hematopoiesis before B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy? aacrjournals.org/clincancerre...

30.11.2025 16:29 — 👍 2    🔁 1    💬 0    📌 0

#FoodInsecurity affects #healthcare workers too.

Efforts like #HCWvsHunger can help.

hcwvshunger.org

30.11.2025 01:52 — 👍 23    🔁 14    💬 0    📌 0
Preview
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification Key PointsThere is poor survival in advanced stage MF/SS.CLIPI stratifies patients with advanced MF/SS into risk groups for survival and has been validated

Now it is imperative to include CLIPI in the routine evaluation of advanced stages Mycosis Fungoides & Sézary syndrome; especially when considering for alloSCT #ctcl

ashpublications.org/blood/articl...

29.10.2025 19:14 — 👍 1    🔁 0    💬 0    📌 0
Preview
Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial In this article by Robert Yeh and colleagues ( BMJ 2018;363:k5094, doi:10.1136/bmj.k5094), the final sentence of the Methods section should …

Reviewing this classic article @bmj.com

Parachute use to prevent death and major trauma when jumping from aircraft: randomized controlled trial

doi.org/10.1136/bmj....

I still teach it all the time

21.10.2025 17:45 — 👍 57    🔁 16    💬 6    📌 5
Post image

Our comprehensive Review on MGUS: Monoclonal Gammopathy of Undetermined Significance @NEJM

5% of people over age 50 have MGUS. Every physician needs to know and understand MGUS. Lots of Tables and Figures. www.nejm.org/doi/abs/10.1...

18.10.2025 12:57 — 👍 13    🔁 3    💬 0    📌 0
Post image

Lo mejor de escuchar a otros especialistas es cuando te encuentras con inmunólogas como la Dra. Silvia Vidal y te da una clase de #XPO #selinexor en el #mieloma
#Hemato2025 @sehhematologia.bsky.social

11.10.2025 12:46 — 👍 0    🔁 1    💬 0    📌 0
Post image

“Manejo periquirúrgico de los pacientes con coagulopatías adquiridas inmunológicas” con Eva Mingot, un enfoque práctico. @hospitaluvrocio.bsky.social @sehhematologia.bsky.social #Hemato2025

11.10.2025 07:49 — 👍 0    🔁 1    💬 0    📌 0
Post image

“Perfil molecular en la leucemia linfática crónica: más allá del TP53”. @ferrannadeu.bsky.social nos revela el universo de complejidad biológica de la #LLC @idibaps.bsky.social @sehhematologia.bsky.social #Hemato2025

11.10.2025 07:05 — 👍 2    🔁 2    💬 0    📌 0
Post image

Rafael de la Cámara nos revela la inmensa cantidad de fármacos antivirales en ensayo para mejorar el cuidado de nuestros pacientes. @sehhematologia.bsky.social #Hemato2025

11.10.2025 06:55 — 👍 0    🔁 1    💬 0    📌 0
Post image

CART de la Mano de Dr. Olalekan O. Oluwole - #Kite #hemato2025 @sehhematologia.bsky.social

09.10.2025 12:37 — 👍 0    🔁 1    💬 0    📌 0
Post image

Secuenciación de tercera generación en el diagnóstico hematológico. Dr. Javier Corral de la Calle repasando la evolución de la NGS. #hemato2025 @sehhematologia.bsky.social

09.10.2025 08:38 — 👍 0    🔁 1    💬 0    📌 0
Post image

Platelet transcriptomic-powered scientific discovery in Thrombosis and Hemostasis Dr. Matthew T. Rondina
Huntsman Cancer Institute & University of Utah Health,
Salt Lake City, Utah (USA). #sepsis #inflamación #hemato2025 ❤️

09.10.2025 07:50 — 👍 1    🔁 1    💬 0    📌 0
HLA-B Leader

bleader.nmdp.org

The HLA-B Leader Assessment Tool (BLEAT) translates HLA-B leader matching based off of the research findings. doi.org/10.1016/S235...

09.10.2025 06:59 — 👍 0    🔁 0    💬 0    📌 0
Post image

“Selection of best donor in allogeneic stem cell transplantation: beyond HLA typing” por la Dra. Effie Wang Petersdorf #hemato2025 #educacional @sehhematologia.bsky.social

09.10.2025 06:45 — 👍 0    🔁 1    💬 1    📌 0
Post image

Es un lujo poder escuchar al Dr. Orfao hablando de la EMR en ls distintas neoplasias hematológicas #Hemato2025 @sehhematologia.bsky.social

09.10.2025 06:27 — 👍 0    🔁 1    💬 0    📌 0
Preview
Limited SUMOylation inhibitor administration enhances eradication of Burkitt’s lymphoma with CD19 CAR-T therapy Signal Transduction and Targeted Therapy - Limited SUMOylation inhibitor administration enhances eradication of Burkitt’s lymphoma with CD19 CAR-T therapy

Administration of SUMOylation inhibitor could eradicate #Burkitt’s #lymphoma treated with CD19 CAR-T.

rdcu.be/eJu9C

04.10.2025 21:03 — 👍 0    🔁 1    💬 0    📌 0
Preview
Reprogramming glutamine metabolism enhances BCMA-CART cell fitness and therapeutic efficacy in multiple myeloma Key Points. Glutamine deprivation in the tumor microenvironment might limit CAR T-cell therapeutic efficacy in cancer patients.ASCT2 overexpression improve

What a beautiful work from our colleagues from Navarra! @unav.edu #CUN
Increasing glutamine uptake may enhance anti-tumor BCMA-CAR T-cell functionality #MM

ashpublications.org/blood/articl...

21.09.2025 20:22 — 👍 0    🔁 1    💬 0    📌 0
Preview
A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for older patients with adult T-cell leukemia/lymphoma Key PointsMoga-CHOP significantly improved 1-year PFS in older patients with aggressive ATL.CCR4 mutations and Moga-associated cAEs were related to better

Improved PFS with Moga-Chop for elderly ATL patients. I wonder how the Moga
-Pembro would work in the same scenario 🧐
ashpublications.org/blood/articl...

21.09.2025 20:10 — 👍 0    🔁 1    💬 0    📌 0
Dansa, resistència i metàfora a l'Hop Festival | Barcelona Cultura Sandra Egido inaugura el festival amb dues peces que fusionen el breaking i la dansa contemporània en clau crítica i poètic... Fes clic per saber-ne més!

🏁Avui #bcnhop #dansaurbana

www.barcelona.cat/barcelonacul...

20.09.2025 11:43 — 👍 0    🔁 0    💬 0    📌 0

🧠 Neurotoxicity in Cancer Therapy
New review (Nat Rev Clin Oncol)

✅ Pathophysiology of chemo-, RT- & IO-induced neurotoxicity
✅ Clinical recognition & biomarkers
✅ Prevention & management strategies

🔍 Key messages – Cavaletti, Cámara, DeAngelis et al. Nat Rev Clin Oncol 2025

15.09.2025 14:36 — 👍 4    🔁 2    💬 1    📌 0
Preview
Touch of youth: Mechanosensing expands stem-like CAR-T cells In this issue of Immunity, Lv et al. develop a new CAR-T cell culture system that uses integrin mechanical signaling to boost CAR-T proliferation while preserving stemness, pointing out a new direction of CAR-T manufacturing.
13.09.2025 19:56 — 👍 2    🔁 2    💬 0    📌 0
Preview
WU Hoo! The Promise of Allogeneic WU-CART-007 in Relapsed/Refractory T-Cell Malignancies Ghobadi A, Aldoss I, Maude SL, . Phase 1/2 trial of anti-CD7 allogenic WU-CART-007 in patients with relapsed/refractory T-cell malignancies. Blood. Publish

WU Hoo! The Promise of Allogeneic WU-CART-007 in Relapsed/Refractory T-Cell Malignancies url: ashpublications.org/thehematolog...

09.09.2025 20:34 — 👍 1    🔁 1    💬 0    📌 0